Mediacenter
Video abspielen
Video abspielen
Interaktiv & Videos
COVID-19 and CytoSorb Therapy | Webinar
1/4 videos
1
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
30:04
2
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
01:27:59
3
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
01:29:34
4
Webinar | CytoSorb therapy in COVID-19 patients
27:58
DIVI | 2019 | Hamburg
1/4 videos
1
Schnelle Schockkontrolle in der Sepsis | DIVI | 2019 | Hamburg
17:27
2
Ein früher Therapiebeginn kann das Outcome verbessern | DIVI | 2019 | Hamburg
13:12
3
ECMO plus CytoSorb | DIVI | 2019 | Hamburg
13:56
4
Medikamentendosierung unter CytoSorb: Anpassungen erforderlich | DIVI 2019 | Hamburg
21:34
6. CytoSorb Anwendertreffen DACH | 2019 | Hamburg
1/10 videos
1
Bedeutung der Hämodynamik und Konsequenzen hoher Katecholamindosierungen | Berthold Bein
20:18
2
CytoSorb zur Kreislaufstabilisierung im vasoplegischen Schock | Karl Träger
22:02
3
Wann beginne ich die Therapie? CytoScore als neue Möglichkeit... | Klaus Kogelmann
17:48
4
Aktuelle Daten zur Sicherheit und Antibiotika-Dosierung unter CytoSorb | Steffen Mitzner
31:31
5
Das CytoSorb-Register – Eine aktuelle Zwischenauswertung | Daniel Dürschmied
06:42
6
CytoSorb und Pruritus | Markus Tölle | 6. CytoSorb Anwendertreffen DACH | 2019 | Hamburg
17:45
7
CytoSorb zur Myoglobin-Entfernung | Stephan Klösel
18:24
8
CytoSorb und ECMO - Erfahrungen aus Freiburg | Alexander Supady
17:06
9
CytoSorb und ECMO - Erfahrungen aus Ibbenbüren | Stephan Ziegeler
13:46
10
CytoSorb beim Leberversagen – Rationale und Übersicht der bisherigen Daten | Jan Stange
13:29
EACTS | 2019 | Lisbon | Symposium
1/17 videos
1
Enhanced hemodynamic and metabolic stability in aortic surgery | EACTS | 2019 | Lisbon |
14:20
2
Improved clinical outcome in ECMO patients | EACTS | 2019 | Lisbon |
18:29
3
Intraoperative use in endocarditis -The REMOVE trial | EACTS | 2019 | Lisbon |
17:20
4
Faster control of refractory vasoplegic shock | Nandor Marczin | EACTS 2019
22:45
5
6
Effects on outcome in mitral valve infective endocarditis | Daniel Wendt | EACTS 2019
15:26
7
Reduction of inflammation in heart transplantation | Endre Németh | EACTS | 2019 | Lisbon
17:27
8
Removal of Ticagrelor | Stephan Geidel | EACTS 2019
20:12
9
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019
13:22
10
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
15:32
11
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
15:32
12
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
15:30
13
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
13:22
14
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Polish Subtitles
13:22
15
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
13:22
16
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
13:22
17
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
13:22
EACTS | 2019 | Lisbon | Symposium mit Untertiteln
1/10 videos
1
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | French Subtitles
15:30
2
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
15:32
3
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
15:30
4
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Polish Subtitles
15:30
5
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
15:32
6
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
13:22
7
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
13:22
8
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
13:22
9
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Polish Subtitles
13:22
10
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
13:22
ESICM Lives 2019 | Berlin
1/5 videos
1
Improved outcome of patients in septic shock | ESICM Lives 2019: Webcast
24:20
2
Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
21:27
3
What makes it unique Rationale of CytoSorb | ESICM Lives 2019: Webcast
20:10
4
Drug removal and safety aspects – what do we currently know | ESICM Lives 2019: Webcast
18:01
5
Improved outcome of patients in septic shock | ESICM Lives 2019: Summary
01:53
Sepsis Update 2019 | Weimar | Symposium Webcast
1/4 videos
1
Hemodynamic changes during hemoadsorption – Which parameters matter | Sepsis Update 2019
18:06
2
Timing and dosing as part of an individualized therapy in septic shock | Sepsis Update 2019
16:04
3
How we use CytoSorb in clinical routine | Sepsis Update 2019
11:24
4
What makes it unique? Rationale and background of CytoSorb Therapy | Sepsis Update 2019
14:22
TCS ECMO 2019 | Paris | Symposium Webcast
1/2 videos
1
TCS ECMO 2019 | Paris | Webcast Pappalardo
11:53
2
TCS ECMO 2019 | Paris | Webcast Traeger
27:23
6th International CytoSorb Users` Meeting | 2019 | Brussels
1/10 videos
1
Welcome - 6th International CytoSorb Users` Meeting
09:06
2
My very special CytoSorb case
11:16
3
My clinical experiences after 100 patients
11:48
4
From experiments to evidence: Safety aspects and drug removal
46:58
5
Hemoadsorption modulates pulmonary metabolism and edema formation
11:56
6
CytoSorb in cardiac arrest
11:08
7
CytoScore helps me to find the right starting point
10:26
8
Opening Lecture: Past, present and future of CytoSorb
30:36
9
CytoSorb in various fields of application: Liver failure
15:04
10
What do we know and what do we have to do? CytoSorb in various fields of application: ECMO
11:34
1. Herzchirurgisches CytoSorb Anwendertreffen | 2019 | Wiesbaden
1/8 videos
1
01 Steiner
10:17
2
02 Deppe
13:39
3
03 Wendt
13:20
4
04 Born
19:09
5
05 Deppe
08:22
6
06 Brünger
12:24
7
07 Träger
30:37
8
08 Hassan
13:43
5. CytoSorb Anwendertreffen DACH | 2018 | Leipzig
1/5 videos
1
01 Praktische Aspekte und neue Erfahrungen im Bereich Sepsis und systemische Hyperinflammation
01:02:34
2
02 Praktische Aspekte und neue Erfahrungen im Bereich Sepsis und systemische Hyperinflammation
28:22
3
03 Praktische Aspekte und neue Erfahrungen im Bereich Rhabdomyolyse
25:12
4
04 Praktische Aspekte und neue Erfahrungen im Bereich Leberversagen
35:21
5
Dr. Christian Steiner, CytoSorbents | 2018 | Leipzig
10:46
EACTS | 2018 | Milan | Symposium Webcast
1/5 videos
1
MOF in ECMO patients and the impact of CytoSorb therapy – 3 years’ experience
09:19
2
Improved outcome of patients undergoing heart transplant with CytoSorb | EACTS | 2018 | Milan
09:34
3
Clinical effects of intraoperative hemoadsorption in acute infective endocarditis – A case series
10:57
4
5
Intraoperative removal of Ticagrelor to reduce bleeding complications... | EACTS | 2018 | Milan
09:13
CytoSorb Aufbau | Anleitung
1/6 videos
1
CytoSorb-Aufbau: Einsatz im kardiopulmonalen Bypass
02:33
2
CytoSorb-Aufbau: Austausch des Adsorbers
02:15
3
CytoSorb-Aufbau: Einsatz hinter dem Dialysator
03:09
4
CytoSorb Aufbau: Einsatz vor dem Dialysator
02:57
5
Hämoperfusion Aufbau für Stand-Alone Anwendung von CytoSorb
02:09
6
CytoSorb ECMO Integration - Deutsch - Animation
03:36
CytoSorb Testimonials
1/6 videos
1
Future – What do you think about the future of CytoSorb?
01:56
2
Early use – When should CytoSorb be started in septic shock?
01:15
3
Safety – How would you describe the safety profile of CytoSorb?
46
4
Ease of use – How easy is the set-up of CytoSorb?
01:05
5
Clinical effects – What are the most impressive clinical effects when you use CytoSorb?
04:37
6
CytoSorb Testimonials
03:30
Haftungsausschluss
Die Aussagen hier geben nur die persönlichen Meinungen und Ansichten des Sprechers wieder und spiegeln nicht notwendigerweise allgemein anerkanntes medizinisches Wissen oder Indikationen wider, die von der beabsichtigten Verwendung von CytoSorb abgedeckt werden.
CytoSorb darf nur von medizinischem Fachpersonal angewendet werden.